View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Dostarlimab 500, Rectal Cancer
Protocol-ID: 2238 V1.0 (Mini), DOST500, Rectal CaIndication(s)
- Rectal Cancer (Mismatch Repair - deficient / Microsatellite Instability - high (dMMR/MSI-H)); ICD-10 C20
Links
- Durable complete responses to PD-1 blockade alone in mismatch repair deficient locally advanced rectal cancer. Authors: Andrea Cercek, Jenna Cohen Sinopoli, Jinru Shia, Jill A. Weiss, Lindsay Temple, Jesse Joshua Smith, Leonard B. Saltz, Maria Widmar, Gerard Fumo, Santiago Aparo, Paul Bernard Romesser, Henry S. Walch, Mitesh Patel, Vetri Sudar Jayaprakasam, Tae-Hyung Kim, Philip Paty, Mithat Gonen, Julio Garcia-Aguilar, Martin R. Weiser, and Luis A Diaz, Jr. [DOI]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 05.01.2023